We are live on ! Find out more
SG

SCHF (GPE) Portfolio holdings

AUM $2.48B
1-Year Est. Return 8.43%
This Fund
S&P 500
This Quarter Est. Return
-10.15%
1 Year Est. Return
-8.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$51.5M
AUM Growth
-$24.6M
Cap. Flow
-$18.7M
Cap. Flow %
-36.26%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
1
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CVET
Covetrus, Inc. Common Stock
CVET
+$9.55M
2
NU icon
Nu Holdings
NU
+$7.34M
3
TOST icon
Toast
TOST
+$1.77M

Sector Composition

Rank Sector Weight
1 Technology 84.69%
2 Financials 12.32%
3 Healthcare 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
U icon
1
Unity
U
$20.3B
$43.6M 84.69%
1,524,149
NU icon
2
Nu Holdings
NU
$71.3B
$6.34M 12.32%
1,557,729
-1,688,671
-52% -$7.34M
LIAN
3
DELISTED
LianBio American Depositary Shares
LIAN
$1.54M 2.99%
937,500
TOST icon
4
Toast
TOST
$21.2B
-105,952
Closed -$1.77M
CVET
5
DELISTED
Covetrus, Inc. Common Stock
CVET
-457,287
Closed -$9.55M

Similar funds

SCHF (GPE)'s Q4 2022 Portfolio in Review

As of Q4 2022, SCHF (GPE) held 5 positions worth $51.5M, down 32% from $76M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SCHF (GPE) withdrew a net $18.7M in Q4 2022, closing 2 positions and reducing 1 holding. Its most notable exit was Covetrus, Inc. Common Stock, an estimated $9.55M position sold in full.

By sector, the portfolio is most concentrated in Technology at 85% of assets, up from 66% a quarter earlier, followed by Financials and Healthcare.

  • SCHF (GPE)'s biggest Q4 2022 reduction was Nu Holdings, cutting an estimated $7.34M.
  • SCHF (GPE) fully exited Covetrus, Inc. Common Stock in Q4 2022, selling an estimated $9.55M.
  • SCHF (GPE)'s ten largest holdings make up 100% of its $51.5M portfolio in Q4 2022.
  • SCHF (GPE) opened 0 new positions and closed 2 in Q4 2022.
  • SCHF (GPE)'s portfolio value fell 32% quarter-over-quarter to $51.5M.

Based on SCHF (GPE)'s 13F filing for Q4 2022, filed 14 Feb 2023.